Jacobs Levy Equity Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
1,475,046
-105,274
| -7% | -$75.5K | ﹤0.01% | 746 |
|
|
2025
Q1 | $2.32M | Sell |
1,580,320
-2,042,706
| -56% | -$3M | 0.01% | 627 |
|
|
2024
Q4 | $16.1M | Sell |
3,623,026
-642,074
| -15% | -$2.84M | 0.06% | 241 |
|
|
2024
Q3 | $17.6M | Sell |
4,265,100
-93,198
| -2% | -$384K | 0.07% | 255 |
|
|
2024
Q2 | $28.4M | Buy |
4,358,298
+122,718
| +3% | +$800K | 0.12% | 179 |
|
|
2024
Q1 | $36.9M | Buy |
4,235,580
+1,226,377
| +41% | +$10.7M | 0.16% | 137 |
|
|
2023
Q4 | $34.4M | Buy |
3,009,203
+630,908
| +27% | +$7.22M | 0.17% | 135 |
|
|
2023
Q3 | $22.9M | Buy |
+2,378,295
| New | +$22.9M | 0.14% | 166 |
|
|
2021
Q3 | – | Sell |
-42,036
| Closed | -$541K | – | 1082 |
|
|
2021
Q2 | $541K | Sell |
42,036
-238,508
| -85% | -$3.07M | ﹤0.01% | 848 |
|
|
2021
Q1 | $3.14M | Buy |
+280,544
| New | +$3.14M | 0.02% | 518 |
|
|
2020
Q2 | – | Sell |
-448,282
| Closed | -$4.52M | – | 1094 |
|
|
2020
Q1 | $4.52M | Sell |
448,282
-480,358
| -52% | -$4.85M | 0.06% | 309 |
|
|
2019
Q4 | $12.4M | Buy |
928,640
+357,597
| +63% | +$4.76M | 0.12% | 207 |
|
|
2019
Q3 | $4.9M | Buy |
571,043
+62,900
| +12% | +$540K | 0.06% | 343 |
|
|
2019
Q2 | $5.56M | Buy |
+508,143
| New | +$5.56M | 0.08% | 322 |
|
|
2015
Q2 | – | Sell |
-20,656
| Closed | -$277K | – | 829 |
|
|
2015
Q1 | $277K | Buy |
+20,656
| New | +$277K | ﹤0.01% | 656 |
|